Q4 2018

Filed Feb 19, 2019 · 10-K · 50 days after period end · 0000877860-19-000006

Q4 2018 · 10-K

Revenue

$74.00M

+4.1% vs Q4 2017

Net Income

$37.08M

−1.9% vs Q4 2017

EPS Diluted

$0.87

−3.3% vs Q4 2017

Operating Cash Flowderived$51,871,000+1.0%

Same quarter

Metric	Q4 2018	Q4 2017	Q4 2016	Q4 2015
Revenue	$74.00M	$71.08M	$64.99M	$58.64M
Net Income	$37.08M	$37.80M	$41.19M	$54.40M
EPS Diluted	$0.87	$0.90	$1.03	$1.44

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR